^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NEO_PLIN2101

    i
    Other names: NEO_PLIN2101, NEO-PLIN2101, PGV002 mRNA vaccine
    Associations

    News

    Trials
    Company:
    NeoCura
    Drug class:
    Immunostimulant, T-cell stimulant
    Related drugs:
    Associations

    News

    Trials
    over1year
    Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors (clinicaltrials.gov)
    P=N/A, N=36, Recruiting, YueJuan Cheng | Not yet recruiting --> Recruiting | Trial completion date: Sep 2025 --> Dec 2025 | Trial primary completion date: Mar 2025 --> Sep 2025
    Enrollment open • Trial completion date • Trial primary completion date • Metastases
    |
    NEO_PLIN2101